THE UNITED States has launched disputes proceedings against Brazil at the World Trade Organisation, complaining that the Latin American country's patent laws allow local drug companies to copy US-patented pharmaceuticals, in contravention of the Agreement on Trade Related Intellectual Property Rights (TRIPS).

Washington DC claims that the existence of a "local working" condition for exclusive patent rights can only be satisfied by local production, and not importation, of medicines, allowing Brazil to sanction the manufacture of generic ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.